124 related articles for article (PubMed ID: 38890736)
1. Unmet needs and harm reduction preferences of syringe services program participants: differences by co-use of illicit opioids and methamphetamine.
Sun R; Sauda TH; Hoopsick RA
Harm Reduct J; 2024 Jun; 21(1):119. PubMed ID: 38890736
[TBL] [Abstract][Full Text] [Related]
2. Understanding the public health consequences of suspending a rural syringe services program: a qualitative study of the experiences of people who inject drugs.
Allen ST; Grieb SM; O'Rourke A; Yoder R; Planchet E; White RH; Sherman SG
Harm Reduct J; 2019 May; 16(1):33. PubMed ID: 31109339
[TBL] [Abstract][Full Text] [Related]
3. Posttraumatic stress disorder in people who use drugs: syringe services program utilization, treatment need, and preferences for onsite mental health care.
López-Castro T; Sohler N; Riback L; Bravo G; Ohlendorf E; Ghiroli M; Fox AD
Harm Reduct J; 2024 Jun; 21(1):108. PubMed ID: 38824597
[TBL] [Abstract][Full Text] [Related]
4. Substance use patterns, sociodemographics, and health profiles of harm reduction service recipients in Burlington, Vermont.
Erath TG; LaCroix R; O'Keefe E; Higgins ST; Rawson RA
Harm Reduct J; 2024 Apr; 21(1):76. PubMed ID: 38580997
[TBL] [Abstract][Full Text] [Related]
5. Differential risks of syringe service program participants in Central Ohio: a latent class analysis.
Moon KJ; Bryant I; Trinh A; Hasenstab KA; Carter B; Barclay R; Nawaz S
Harm Reduct J; 2023 Jul; 20(1):97. PubMed ID: 37507721
[TBL] [Abstract][Full Text] [Related]
6. Interest in reducing methamphetamine and opioid use among syringe services program participants in Washington State.
McMahan VM; Kingston S; Newman A; Stekler JD; Glick SN; Banta-Green CJ
Drug Alcohol Depend; 2020 Nov; 216():108243. PubMed ID: 32911134
[TBL] [Abstract][Full Text] [Related]
7. Signals of increasing co-use of stimulants and opioids from online drug forum data.
Sarker A; Al-Garadi MA; Ge Y; Nataraj N; Jones CM; Sumner SA
Harm Reduct J; 2022 May; 19(1):51. PubMed ID: 35614501
[TBL] [Abstract][Full Text] [Related]
8. Hospital admissions among people who inject opioids following syringe services program implementation.
Bornstein KJ; Coye AE; St Onge JE; Li H; Muller A; Bartholomew TS; Tookes HE
Harm Reduct J; 2020 May; 17(1):30. PubMed ID: 32398059
[TBL] [Abstract][Full Text] [Related]
9. Associations between perceived illicit fentanyl use and infectious disease risks among people who inject drugs.
Lambdin BH; Bluthenthal RN; Zibbell JE; Wenger L; Simpson K; Kral AH
Int J Drug Policy; 2019 Dec; 74():299-304. PubMed ID: 31733979
[TBL] [Abstract][Full Text] [Related]
10. A qualitative study of service engagement and unmet needs among unstably housed people who inject drugs in Massachusetts.
Hassan R; Roland KB; Hernandez B; Goldman L; Evans KN; Gaul Z; Agnew-Brune C; Buchacz K; Fukuda HD
J Subst Abuse Treat; 2022 Jul; 138():108722. PubMed ID: 35067399
[TBL] [Abstract][Full Text] [Related]
11. Motivations for crystal methamphetamine-opioid co-injection/co-use amongst community-recruited people who inject drugs: a qualitative study.
Palmer A; Scott N; Dietze P; Higgs P
Harm Reduct J; 2020 Feb; 17(1):14. PubMed ID: 32106854
[TBL] [Abstract][Full Text] [Related]
12. Fentanyl test strips as an opioid overdose prevention strategy: Findings from a syringe services program in the Southeastern United States.
Peiper NC; Clarke SD; Vincent LB; Ciccarone D; Kral AH; Zibbell JE
Int J Drug Policy; 2019 Jan; 63():122-128. PubMed ID: 30292493
[TBL] [Abstract][Full Text] [Related]
13. Consuming illicit opioids during a drug overdose epidemic: Illicit fentanyls, drug discernment, and the radical transformation of the illicit opioid market.
Duhart Clarke SE; Kral AH; Zibbell JE
Int J Drug Policy; 2022 Jan; 99():103467. PubMed ID: 34662847
[TBL] [Abstract][Full Text] [Related]
14. Motivation and context of concurrent stimulant and opioid use among persons who use drugs in the rural United States: a multi-site qualitative inquiry.
Fredericksen RJ; Baker R; Sibley A; Estadt AT; Colston D; Mixson LS; Walters S; Bresett J; Levander XA; Leichtling G; Davy-Mendez T; Powell M; Stopka TJ; Pho M; Feinberg J; Ezell J; Zule W; Seal D; Cooper HLF; Whitney BM; Delaney JAC; Crane HM; Tsui JI
Harm Reduct J; 2024 Apr; 21(1):74. PubMed ID: 38561753
[TBL] [Abstract][Full Text] [Related]
15. From opiates to methamphetamine: building new harm reduction responses in Jakarta, Indonesia.
Rigoni R; Woods S; Breeksema JJ
Harm Reduct J; 2019 Dec; 16(1):67. PubMed ID: 31829253
[TBL] [Abstract][Full Text] [Related]
16. Intravenous fentanyl use among people who inject drugs in Australia.
Geddes L; Iversen J; Memedovic S; Maher L
Drug Alcohol Rev; 2018 Apr; 37 Suppl 1():S314-S322. PubMed ID: 29405465
[TBL] [Abstract][Full Text] [Related]
17. Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey.
Scheibe A; Young K; Moses L; Basson RL; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Manamela J; Puren AJ; Rebe K; Hausler H
Harm Reduct J; 2019 Apr; 16(1):28. PubMed ID: 30975139
[TBL] [Abstract][Full Text] [Related]
18. Association of Methamphetamine and Opioid Use With Nonfatal Overdose in Rural Communities.
Korthuis PT; Cook RR; Foot CA; Leichtling G; Tsui JI; Stopka TJ; Leahy J; Jenkins WD; Baker R; Chan B; Crane HM; Cooper HL; Feinberg J; Zule WA; Go VF; Estadt AT; Nance RM; Smith GS; Westergaard RP; Van Ham B; Brown R; Young AM
JAMA Netw Open; 2022 Aug; 5(8):e2226544. PubMed ID: 35969400
[TBL] [Abstract][Full Text] [Related]
19. Adaptation of the Tele-Harm Reduction intervention to promote initiation and retention in buprenorphine treatment among people who inject drugs: a retrospective cohort study.
Suarez E; Bartholomew TS; Plesons M; Ciraldo K; Ostrer L; Serota DP; Chueng TA; Frederick M; Onugha J; Tookes HE
Ann Med; 2023 Dec; 55(1):733-743. PubMed ID: 36856571
[No Abstract] [Full Text] [Related]
20. How far will they go? Assessing the travel distance of current and former drug users to access harm reduction services.
Allen S; Ruiz M; O'Rourke A
Harm Reduct J; 2015 Mar; 12():3. PubMed ID: 25889589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
